These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
394 related articles for article (PubMed ID: 32513669)
21. Advances in smoking cessation pharmacotherapy: Non-nicotinic approaches in animal models. Smith LC; George O Neuropharmacology; 2020 Nov; 178():108225. PubMed ID: 32758566 [TBL] [Abstract][Full Text] [Related]
22. Implications of gene-drug interactions in smoking cessation for improving the prevention of chronic degenerative diseases. Quaak M; van Schayck CP; Knaapen AM; van Schooten FJ Mutat Res; 2009 Jul; 667(1-2):44-57. PubMed ID: 19028511 [TBL] [Abstract][Full Text] [Related]
23. Neurobehavioral mechanisms of nicotine action: role in the initiation and maintenance of tobacco dependence. Rosecrans JA; Karan LD J Subst Abuse Treat; 1993; 10(2):161-70. PubMed ID: 8510190 [TBL] [Abstract][Full Text] [Related]
24. Nicotine and opioid co-dependence: Findings from bench research to clinical trials. Custodio L; Malone S; Bardo MT; Turner JR Neurosci Biobehav Rev; 2022 Mar; 134():104507. PubMed ID: 34968525 [TBL] [Abstract][Full Text] [Related]
32. Endogenous opioid system: a promising target for future smoking cessation medications. Norman H; D'Souza MS Psychopharmacology (Berl); 2017 May; 234(9-10):1371-1394. PubMed ID: 28285326 [TBL] [Abstract][Full Text] [Related]
33. Nicotine Acutely Enhances Reinforcement from Non-Drug Rewards in Humans. Perkins KA; Karelitz JL; Boldry MC Front Psychiatry; 2017; 8():65. PubMed ID: 28507522 [TBL] [Abstract][Full Text] [Related]
34. Progesterone Increases Nicotine Withdrawal and Anxiety in Male but Not Female Smokers During Brief Abstinence. Novick AM; Duffy KA; Johnson RL; Sammel MD; Cao W; Strasser AA; Sofuoglu M; Kuzma A; Loughead J; Epperson CN Nicotine Tob Res; 2022 Nov; 24(12):1898-1905. PubMed ID: 35713950 [TBL] [Abstract][Full Text] [Related]
35. CC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation. Sala M; Braida D; Pucci L; Manfredi I; Marks MJ; Wageman CR; Grady SR; Loi B; Fucile S; Fasoli F; Zoli M; Tasso B; Sparatore F; Clementi F; Gotti C Br J Pharmacol; 2013 Feb; 168(4):835-49. PubMed ID: 22957729 [TBL] [Abstract][Full Text] [Related]
36. Understanding the implications of the biobehavioral basis of nicotine addiction and its impact on the efficacy of treatment. Bozinoff N; Le Foll B Expert Rev Respir Med; 2018 Sep; 12(9):793-804. PubMed ID: 30092681 [TBL] [Abstract][Full Text] [Related]
38. Scientific Evidence for the Addictiveness of Tobacco and Smoking Cessation in Tobacco Litigation. Roh S J Prev Med Public Health; 2018 Jan; 51(1):1-5. PubMed ID: 29397646 [TBL] [Abstract][Full Text] [Related]
39. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial. Shiffman S Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988 [TBL] [Abstract][Full Text] [Related]
40. Are tobacco dependence and withdrawal related amongst heavy smokers? Relevance to conceptualizations of dependence. Baker TB; Piper ME; Schlam TR; Cook JW; Smith SS; Loh WY; Bolt D J Abnorm Psychol; 2012 Nov; 121(4):909-21. PubMed ID: 22642839 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]